Early stage pharmacologic characterization studies showed CP-724714 to be a potent autophosphorylation inhibitor and G1 cell cycle blocking inducer in HER2-overexpressing BT474 human breast carcinoma cells [60]. This evidence concerns the gene ERBB2 and breast carcinoma.